Literature DB >> 25355710

Afrezza inhaled insulin: the fastest-acting FDA-approved insulin on the market has favorable properties.

David C Klonoff1.   

Abstract

Entities:  

Keywords:  Afrezza; diabetes; inhaled insulin; pulmonary

Mesh：

Substances：

Year:  2014        PMID： 25355710      PMCID： PMC4455463          DOI： 10.1177/1932296814555820

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  1 in total

1.  Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.

Authors:  Julio Rosenstock; Daniel L Lorber; Luigi Gnudi; Campbell P Howard; David W Bilheimer; P-C Chang; Richard E Petrucci; Anders H Boss; Peter C Richardson
Journal:  Lancet       Date:  2010-06-26       Impact factor: 79.321
  1 in total
  8 in total

1.  Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion.

Authors:  Howard Zisser; Eyal Dassau; Justin J Lee; Rebecca A Harvey; Wendy Bevier; Francis J Doyle
Journal:  J Diabetes Sci Technol       Date:  2015-04-21

Review 2.  Cyclic Peptides that Govern Signal Transduction Pathways: From Prokaryotes to Multi-Cellular Organisms.

Authors:  Ryan W Mull; Anthony Harrington; Lucia A Sanchez; Yftah Tal-Gan
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

Review 3.  Place of technosphere inhaled insulin in treatment of diabetes.

Authors:  Nasser Mikhail
Journal:  World J Diabetes       Date:  2016-12-15

Review 4.  Advances in Type 1 Diabetes Technology Over the Last Decade.

Authors:  Chelsea Zimmerman; Anastasia Albanese-O'Neill; Michael J Haller
Journal:  Eur Endocrinol       Date:  2019-08-16

Review 5.  Insulin-delivery methods for children and adolescents with type 1 diabetes.

Authors:  Zavuga Zuberi; Elingarami Sauli; Liu Cun; Jing Deng; Wen-Jun Li; Xu-Liang He; Wen Li
Journal:  Ther Adv Endocrinol Metab       Date:  2020-05-08       Impact factor: 3.565

Review 6.  Bioanalytical Methods and Strategic Perspectives Addressing the Rising Complexity of Novel Bioconjugates and Delivery Routes for Biotherapeutics.

Authors:  Ruipeng Mu; Jiaqi Yuan; Yue Huang; John K Meissen; Si Mou; Meina Liang; Anton I Rosenbaum
Journal:  BioDrugs       Date:  2022-04-01       Impact factor: 7.744

Review 7.  Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges.

Authors:  Isaura Beatriz Borges Silva; Camila Harumi Kimura; Vitor Prado Colantoni; Mari Cleide Sogayar
Journal:  Stem Cell Res Ther       Date:  2022-07-15       Impact factor: 8.079

8.  A Model-Informed Drug Discovery and Development Strategy for the Novel Glucose-Responsive Insulin MK-2640 Enabled Rapid Decision Making.

Authors:  Sandra A G Visser; Bhargava Kandala; Craig Fancourt; Alexander W Krug; Carolyn R Cho
Journal:  Clin Pharmacol Ther       Date:  2020-02-03       Impact factor: 6.875
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.